Fiche publication
Date publication
avril 2026
Journal
Annals of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PESSAUX Patrick
Tous les auteurs :
Giannone F, Palucci M, Cassese G, Capretti G, Ginesini M, Iben-Khayat A, De Rosa RV, Ricci C, Lupascu CD, Marchese U, Sánchez-Velázquez P, Rossi R, Rhaiem R, Deloche G, Rompianesi G, Fernández-Baeza M, Gruttadauria S, Dulundu E, Baiocchi GL, Spampinato M, Memeo R, Frigerio I, Chenevas-Paule Q, Miggino M, Grazi GL, Ercolani G, Espin F, Serradilla-Martín M, Troisi RI, Truant S, Piardi T, Vivarelli M, Pessaux P, Ielpo B, Tzedakis S, Chicos A, Casadei R, Sulpice L, Saint-Marc O, Boggi U, Zerbi A, Panaro F,
Lien Pubmed
Résumé
Up to 40% of patients undergoing pancreatoduodenectomy (PD) for resectable pancreatic ductal adenocarcinoma do not receive adjuvant chemotherapy (aCT). This study aimed to evaluate the impact of postoperative pancreatic fistula (POPF) on aCT delivery and timing and to explore how preoperative variables influence these outcomes according to the occurrence of a POPF.
Mots clés
Adjuvant chemotherapy, Conditional status, Pancreatic cancer, Pancreatic fistula, Pancreatoduodenectomy
Référence
Ann Surg Oncol. 2026 04 24;:
